rejuvant life tabs

Muhdo partner with NUS in advanced longevity research

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

National University of Singapore and Muhdo Heath set to collaborate on an advanced global research project on longevity analysing epigenetic change.

Muhdo Health announced today it is joining forces with the National University of Singapore (NUS) and Professor Brian Kennedy to bring about one the most advanced research projects focused on healthy aging and longevity ever undertaken. The research will take place on a global scale, involving the analysis of epigenetic changes on the human body. The study will focus on the changes that occur during aging and the effects that lifestyle and environment have on gene expression.

Longevity.Technology: Last week we covered Muhdo’s announcement that they are partnering with ARK-KCL in an advanced research project around epigenetics, AI and informatics. Today’s announcement further cements their position as a key player in the epigenetics space. 

Unlike the outdated and conventional method of measuring age with time, epigenetic aging, also known as biological age, can be accelerated and reversed. Participants will be analysed while living their normal, everyday lives, through their stressors and environmental challenges with epigenetic aging being analysed through DNA methylation.

Brian Kennedy
Prof Brian Kennedy, Director, Centre for Healthy Ageing, NUS

DNA methylation has been argued to be related to all mortality in later life, however, it is thought not to be a cause of aging but a marker that can be used to judge accelerated aging. By using this important marker, it may be possible to predict many disease and lifestyle conditions before they come to pass.

Elevant

Prevention is the best cure

With the fundamental aim of decelerating the aging process and preventing these ailments from occurring in the first place, Muhdo has built its DNA and epigenetic offering to be accessed through a ground-breaking mobile application. This application will also be available to the participants in the study in a white label form, highlighting the technological advances in the study and information sharing of DNA analysis.

Nathan Berkley Muhdo
Nathan Berkley, CEO, Muhdo

“We at Muhdo are very excited to be aiding NUS carry out this cutting-edge research with the custom Muhdo analysis and mobile application,” said Muhdo CEO Nathan Berkley. “DNA and epigenetics has the capability to help everyone at every stage of life to reach their full health potential. We believe this is a true milestone in the global application of epigenetics.”

Elevant

Professor Brian Kennedy said: “We’re always searching for novel ways to push the boundaries of our research at NUS and epigenetics is at the pinnacle of human longevity and genetic science. Everyone involved at NUS is very excited to be able to bring our studies to fruition with the aid of Muhdo. We believe, above all else, that we will reach invaluable conclusions that will reverberate for years to come.”

Image credits:  Jason GohPixabay, Prof Brian Kennedy and Nathan Berkley

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

First non-invasive biomarker to track and verify senolytics

Researchers at The Buck Institute develop a biomarker test for senolytics, paving the way for senotherapeutic treatments. Buck Institute researchers have discovered and are developing...

Bats’ contribution to DNA methylation research

New research into DNA methylation to accurately predict maximum lifespan and support longevity R&D. The study of reversible DNA modifications, known as epigenetics, has played...

Light at the end of the Alzheimer’s tunnel

Professor José Viña on early detection of Alzheimer's and reasons to be hopeful. Professor Viña is head of the successful FRESHAGE research group at the...

New aging clock is a key longevity tool

A new aging clock that's close to the theoretical limit of accuracy boasts unprecedented precision and offers new insights into how the aging process...
Supps report ad middle